Vertex Pharmaceuticals

@VertexPharma

The official channel for Vertex Pharmaceuticals. bit.ly/3Bvj6WE

Boston, MA

Vertex Pharmaceuticals
@VertexPharma
Aug 26
We have entered a new reimbursement agreement for our latest #CysticFibrosis (CF) therapy in #Latvia. This new agreement has enabled broad access for eligible people living with CF ages 6 years and older since August 17, 2026.
1
Vertex Pharmaceuticals
@VertexPharma
Aug 6
Extended reimbursement agreement with health authorities in #Uruguay: Since July 2026 eligible children living with #CysticFibrosis ages 2 years and older have broad access to one of our medicines.
2
Vertex Pharmaceuticals
@VertexPharma
Jul 6
Today we announced an agreement to acquire @Crinetics. This deal adds to our portfolio of transformative medicines & leverages our strengths in R&D & commercialization to bring more potentially best-in-class medicines to patients with serious diseases. news.vrtx.com/news-releases/…
4
Vertex Pharmaceuticals
@VertexPharma
Jul 2
A landmark update for children living with #SickleCellDisease or #TransfusionDependentBetaThalassemia: The @US_FDA has approved a label extension for our #CRISPR-based therapy. Learn more: news.vrtx.com/news-releases/…
1
Vertex Pharmaceuticals
@VertexPharma
Jun 11
We presented data on our gene-edited therapy for people with sickle cell disease or transfusion-dependent beta thalassemia at the European Hematology Association (EHA) Congress and announced regulatory submissions for potential future use in additional patients. Find out more:
1